Genomic-guided precision therapy for soft tissue sarcoma.

ESMO Open
Hsing-Wu Chen, Tom Wei-Wu Chen

Abstract

Soft tissue sarcoma (STS), although heterogeneous in histopathology presentation, has mostly been treated with chemotherapy agents as one entity. Our understanding of crucial genomic alterations in different STS histologies and the advent of molecular-targeted agents have reshaped the treatment paradigm for advanced STS. Small-molecule inhibitors of c-KIT, plate-derived growth factor receptor alpha, c-MET, BRAF, anaplastic lymphoma kinase, ROS1 and colony-stimulating factor-1 receptor have been successfully validated in clinical studies to yield practice-changing results. Inhibitors of other novel genomic targets including mouse double minute 2 homolog, cyclin-dependent kinase 4/6, mitogen-activated protein kinase and epigenetic regulators are expected to be developed in the near future. Furthermore, with the advancement and accessibility of molecular diagnosis and next-generation sequencing, a genomic-based therapeutic approach should be widely applicable to advanced STS patients. This review will focus on the progress of genomic-guided therapy tailored to each molecular alteration of different STS histologies.

References

Mar 1, 1992·The American Journal of Surgical Pathology·F BonettiG Zamboni
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Jan 19, 2005·The American Journal of Gastroenterology·Thomas TranHashem B El-Serag
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Robert B WestMatt van de Rijn
Apr 21, 2006·The American Journal of Surgical Pathology·Jared J AbbottAntonio G Nascimento
Oct 17, 2007·Journal of Clinical Pathology·B C Gleason, J L Hornick
Dec 15, 2007·Virchows Archiv : an International Journal of Pathology·Guido MartignoniFranco Bonetti
Feb 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles D BlankeHeikki Joensuu
Jan 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew J WagnerRobert G Maki
Mar 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Piotr RutkowskiUNKNOWN Southwest Oncology Group
Mar 11, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A ItalianoB Bui
Oct 29, 2010·The New England Journal of Medicine·James E ButrynskiGeoffrey I Shapiro
Mar 25, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kengo TakeuchiYuichi Ishikawa
Sep 22, 2011·The American Journal of Surgical Pathology·Travis J Hollmann, Jason L Hornick
Nov 18, 2011·Nature Reviews. Cancer·Christopher L CorlessMichael C Heinrich
Feb 1, 2012·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Benjamin BoguckiEva A Hurst
Jun 22, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Philippe A CassierUNKNOWN European Organisation for Research and Treatment of Cancer
Apr 10, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark A DicksonGary K Schwartz
Aug 15, 2013·Current Opinion in Oncology·Andrew E Rosenberg
Mar 13, 2014·The Lancet Oncology·Ian JudsonUNKNOWN European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
May 31, 2014·Cancer Discovery·Christine M LovlyCheryl M Coffin
Jan 24, 2015·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Jason L HornickChristine M Lovly
Jul 30, 2015·The New England Journal of Medicine·William D TapGideon Bollag
Sep 16, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George D DemetriShreyaskumar R Patel
Dec 10, 2015·Histopathology·Hidetaka YamamotoYoshinao Oda
Feb 6, 2016·Nature Medicine·Kimberly H Kim, Charles W M Roberts
May 27, 2016·Nature Reviews. Disease Primers·Elizabeth P HenskeElizabeth A Thiele

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
Transfection
surgical resection
ubiquitination
surgical
biopsy
PCR

Clinical Trials Mentioned

NCT03433183

Software Mentioned

INVICTUS
OncoKB
ENLIVEN

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.